Helicobacter pylori infection is strongly linked to gastric carcinoma. Only a small proportion of those infected develop gastric cancer. While host and environmental factors and genetic predisposition are likely to be important, the microorganism appears pivotal in """"""""providing"""""""" the proper environment of atrophic pangastritis. For almost all bacterial pathogens studied to date, the majority of clinically significant disease outbreaks are caused by a very small percentage of the extant clones of a species. Recent large scale studies of genetic structure in natural populations of pathogenic bacteria revealed disease nature and severity were associated with specific clones of bacteria. The goal of this proposal is to clarify the role of Hp in gastric carcinoma by determining whether distinct Hp strains are more frequently associated with gastric cancer than duodenal ulcer, a disease with no association with gastric carcinoma. Putative genetic factors from these specific strains responsible for virulence will be identified and characterized. We will generate DNA fingerprints based on amplification of genomic regions between repetitive elements, a proven method for discriminating between strains within a species population. We intend to use the REP-PCR technique to generate genotypes for each strain obtained from gastric cancer patients and compare these with the fingerprints from strains obtained from first degree relatives and with strains from patients with non-malignant gastroduodenal disease such as simple gastritis and duodenal ulcer disease. Identification of disease-specific Hp cell lineages and their potential virulence factors will expand our knowledge of the mechanisms underlying the role of Hp in the pathogenesis of various gastrointestinal diseases and should lead to the development of more effective methods to investigate, treat, and prevent Hp-associated gastroduodenal disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA067469-04
Application #
2700608
Study Section
Special Emphasis Panel (SRC (24))
Program Officer
Hall, Leota
Project Start
1995-05-05
Project End
2000-04-30
Budget Start
1998-05-01
Budget End
2000-04-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Li, Li; Genta, Robert M; Go, Mae F et al. (2002) Helicobacter pylori strain and the pattern of gastritis among first-degree relatives of patients with gastric carcinoma. Helicobacter 7:349-55
Li, Li; Graham, David Y; Gutierrez, Oscar et al. (2002) Genomic fingerprinting and genotyping of Helicobacter pylori strains from patients with duodenal ulcer or gastric cancer from different geographic regions. Dig Dis Sci 47:2512-8
Go, M F; Crowe, S E (2000) Virulence and pathogenicity of Helicobacter pylori. Gastroenterol Clin North Am 29:649-70
Hansen, P S; Go, M F; Varming, K et al. (1999) Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori is not associated with cagA, vacA or picB genotypes. APMIS 107:1117-23
Miehlke, S; Thomas, R; Guiterrez, O et al. (1999) DNA fingerprinting of single colonies of Helicobacter pylori from gastric cancer patients suggests infection with a single predominant strain. J Clin Microbiol 37:245-7
El-Zimaity, H M; Graham, D Y (1999) Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol 30:72-7
Miehlke, S; Genta, R M; Graham, D Y et al. (1999) Molecular relationships of Helicobacter pylori strains in a family with gastroduodenal disease. Am J Gastroenterol 94:364-8
Li, L; Kelly, L K; Ayub, K et al. (1999) Genotypes of Helicobacter pylori obtained from gastric ulcer patients taking or not taking NSAIDs. Am J Gastroenterol 94:1502-7
Hansen, P S; Go, M F; Varming, K et al. (1999) Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori in patients with different clinical presentations. Infect Immun 67:3171-4
Graham, D Y; Anderson, S Y; Lang, T (1999) Garlic or jalapeno peppers for treatment of Helicobacter pylori infection. Am J Gastroenterol 94:1200-2

Showing the most recent 10 out of 13 publications